Breakingviews columnists review Abbott Labs' seemingly value-destructive $25 bln deal to buy St. Jude Medical and AbbVie's blowout price for a Silicon Valley cancer drug developer.
from Reuters Video: Breakingviews http://ift.tt/1qYpQWJ
via IFTTT
No comments:
Post a Comment